Achievements
-
.96mcourses of SMC
delivered to 13 countries in 2019, enough to protect more than 20 million children
-
.1stnew medicine
for the radical cure of relapsing P. vivax malaria in more than 60 years, approved by the US FDA and Australian TGA
-
.168mvials
of injectable artesunate for severe malaria delivered since 2010, saving the lives of over 1m additional vulnerable children compared with quinine treatment
Defeating malaria together
Featured resources
-
MMV At a glance
The MMV at a glance highlights our unique partnership model, the growth of our portfolio and the increasing impact of our access work.
Jun 2020 -
Next-generation researchers: in malaria and beyond
Next-generation researchers in malaria and other neglected diseases discuss their work and aspirations.
Jun 2020 -
MiMBa: Malaria in Mothers and Babies
MMV’s MiMBa strategy aims to raise the standard of care for pregnant women and their newborns affected by malaria.
Mar 2020
Events
There are currently no upcoming events.